Table 1 Demographic characteristics, vaccination and clinical history of AFP cases, Kenya, 2016–2018
From: An epidemiological analysis of Acute Flaccid Paralysis (AFP) surveillance in Kenya, 2016 to 2018
Demographic characteristics and clinical history | Year of onset of paralysis | ||
|---|---|---|---|
2016 N (%) | 2017 N (%) | 2018 N (%) | |
Age | |||
0–5 | 365 (64.4%) | 284 (62.0%) | 436 (64.0%) |
6–9 | 90 (15.9%) | 77 (16.8%) | 127 (18.6%) |
10–15+ | 112 (19.8%) | 88 (19.2%) | 103 (15.1%) |
Missing | 0 (0.0%) | 9 (2.0%) | 15 (2.2%) |
Sex | |||
Male | 322 (56.8%) | 221 (48.3%) | 376 (55.2%) |
Female | 240 (42.3%) | 210 (45.8%) | 305 (44.8%) |
Missing | 5 (0.9%) | 17 (5.9%) | 0 (0.0%) |
Vaccination status | |||
Zero dose | 1 (0.2%) | 2 (0.4%) | 12 (1.8%) |
1–2 doses | 38 (6.7%) | 58 (12.7%) | 52 (7.6%) |
3+ doses | 511 (90.1%) | 398 (86.9%) | 594 (87.2%) |
Missing | 17 (3.0%) | 0 (0.0%) | 23 (3.4%) |
Clinical history | |||
Fever at onset of paralysis | 394 (69.5%) | 285 (62.2%) | 420 (61.7%) |
Paralysis progressed within 3 days | 330 (58.2%) | 275 (60.0%) | 371 (54.5%) |
Asymmetrical paralysis | 529 (93.3%) | 157 (34.3%) | 603 (88.5%) |
Flaccid sudden onset of paralysis | 340 (60.0%) | 392 (85.6%) | 172 (25.3%) |